Maravai LifeSciences Announces August and September 2024 Investor Conference Schedule
Rhea-AI Summary
Maravai LifeSciences (NASDAQ: MRVI), a global provider of life science reagents and services, has announced its participation in three upcoming investor conferences. CEO Trey Martin will join a panel discussion at the UBS Genomic Medicine Conference on August 14, 2024. Martin and CFO Kevin Herde will participate in fireside chats at the Wells Fargo Healthcare Conference on September 4 and the Morgan Stanley Healthcare Conference on September 5, 2024.
All presentations will be webcast live on the Maravai LifeSciences Investor Relations website, with archived versions available after the events. These conferences provide opportunities for Maravai to showcase its position in the life sciences industry and engage with investors.
Positive
- Participation in three major investor conferences, potentially increasing visibility and investor interest
- Live webcasts of presentations available, enhancing transparency and accessibility for investors
Negative
- None.
News Market Reaction
On the day this news was published, MRVI gained 1.87%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
SAN DIEGO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conferences in August and September.
On August 14, 2024, at 11:00 a.m. PDT/ 2:00 p.m. EDT, Trey Martin, Chief Executive Officer, will participate in a panel discussion of the Critical Components of the Genomic Medicine Supply Chain at the UBS Genomic Medicine Conference in Dana Point, CA.
On September 4, 2024, at 6:30 a.m. PDT/ 9:30 a.m. EDT, Trey Martin, Chief Executive Officer, and Kevin Herde, Chief Financial Officer, will participate in a fireside chat at the Wells Fargo Healthcare Conference in Boston, MA.
On September 5, 2024, at 1:50 p.m. PDT/ 4:50 p.m. EDT, Trey Martin, Chief Executive Officer, and Kevin Herde, Chief Financial Officer, will participate in a fireside chat at the Morgan Stanley Healthcare Conference in New York, NY.
A live webcast of each presentation will be available to all interested parties on the Maravai LifeSciences Investor Relations website, under News & Events, Upcoming events. An archived version of the webcast will also be available on the Maravai website after the event is completed.
About Maravai
Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world’s leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapies companies.
For more information about Maravai LifeSciences, visit www.maravai.com.
Contact Information:
Investor Contact:
Deb Hart
Maravai LifeSciences
+1 858-988-5917
ir@maravai.com
FAQ
When is Maravai LifeSciences (MRVI) participating in the UBS Genomic Medicine Conference?
Who will represent Maravai LifeSciences (MRVI) at the Wells Fargo Healthcare Conference?
Where can investors access the webcasts of Maravai LifeSciences' (MRVI) conference presentations?
What is the date and time of Maravai LifeSciences' (MRVI) presentation at the Morgan Stanley Healthcare Conference?
